However, in the finisher phase, the analysis shows a slight trend towards increased ADG with full doses, though this trend does not reach statistical significance at the conventional 0.05 level. 3.2.4.
← all excerpts
Causal inference study of PRRSV-MLV vaccine dosing effects on wean-to-finish performance during outbreaks.
1
—
—